Clinical trial
Valproic Acid Sodium Salt in Bipolar Disorder
NCT00431522 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00431522 |
|---|---|
| Title | Valproic Acid Sodium Salt in Bipolar Disorder |
| Official title | Protective Effect of Valproate on Brain Cells:A Magnetic Resonance Imaging and Spectroscopy Study in Patients With Bipolar Disorder Diagnosis |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | Valproic acid, sodium salt |
| Enrollment | 58 |
| Start date | Dec 1, 2004 |
| Primary completion | Oct 1, 2006 |
| Completion | Oct 1, 2006 |
| First posted | Feb 5, 2007 |
| Last update posted | May 29, 2009 |
| Countries | Turkey (Türkiye) |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: